Chief Financial Officer, Carlsmed
Alex is a MedTech finance executive and former equity analyst. He led equity research for Lazard Capital Markets and Wedbush Morgan, and held operating roles at private and public companies, including Biolase, Circuit Therapeutics, and Arstasis. Alex currently serves as a Board Member at Zelegent, Paragonix Technologies, and 8i Acquisition Corp and previously served on the boards of Medcura, Neumedicines, and Biolase. Alex has an M.D. from Harvard Medical School, a B.A. in Biophysics from Cornell University, and is a CFA charter holder.